0001209191-11-029540.txt : 20110518
0001209191-11-029540.hdr.sgml : 20110518
20110518195553
ACCESSION NUMBER: 0001209191-11-029540
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110509
FILED AS OF DATE: 20110518
DATE AS OF CHANGE: 20110518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gillespie Deirdre
CENTRAL INDEX KEY: 0001354737
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24274
FILM NUMBER: 11856151
MAIL ADDRESS:
STREET 1: 416 MARLBOROUGH STREET
STREET 2: APT. 707
CITY: BOSTON
STATE: MA
ZIP: 02115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584526600
MAIL ADDRESS:
STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-05-09
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001354737
Gillespie Deirdre
4365 EXECUTIVE DRIVE, SUITE 300
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Common Stock
2011-05-09
4
M
0
99166
0.006
A
99166
D
Common Stock
2011-05-17
4
S
0
99166
0.016
D
0
D
Series C-1 Convertible Preferred
0.006
2011-05-09
4
M
0
0.595
595.00
D
Common
99166
111.205
D
Shares issued on conversion of Series C-1 Convertible Preferred. The Series C-1 Convertible Preferred has a face value of $1,000 per share and was convertible into Common Stock at a ratio of 166,667 shares of Common Stock per share of Series C-1 Convertible Preferred.
Reflects the price following a one-time adjustment on May 7, 2011 after the Company's 100 to 1 reverse split.
Exercisable date is not applicable.
Expiration date is not applicable.
/s/ Deirdre Y. Gillespie
2011-05-18